Hutchmed (China)
HCM
Enerpac Tool
EPAC
Ermenegildo Zegna NV
ZGN
Lantheus
LNTH
eBay
EBAY
US Stock MarketDetailed Quotes
TVTX Travere Therapeutic
- 20.650
- -0.580-2.73%
Close Feb 25 16:00 ET
- 22.194
- +1.544+7.48%
Post 20:01 ET
1.83BMarket Cap-5.06P/E (TTM)
21.780High20.390Low2.68MVolume21.580Open21.230Pre Close55.91MTurnover3.55%Turnover RatioLossP/E (Static)88.74MShares25.29052wk High31.01P/B1.56BFloat Cap5.12052wk Low--Dividend TTM75.50MShs Float37.040Historical High--Div YieldTTM6.55%Amplitude0.000Historical Low20.840Avg Price1Lot Size
About Travere Therapeutic Company
Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
Company Profile
SymbolTVTX
Company NameTravere Therapeutic
Listing DateJan 10, 2014
Founded2008
CEODr. Eric M. Dube, PhD
MarketNASDAQ
Employees385
Fiscal Year Ends12-31
Address3611 Valley Centre Drive,Suite 300
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-888-969-7879
Websitehttp://www.travere.com
Company Executives
- Name
- Position
- Salary
- Dr. Eric M. Dube, PhD
- Director, President and Chief Executive Officer
- 7.57M
- Christopher Cline
- Chief Financial Officer
- 1.97M
- Peter Heerma
- Chief Commercial Officer
- 2.00M
- Sandra Calvin
- Senior Vice President and Chief Accounting Officer
- --
- Dr. Jula Inrig
- Chief Medical Officer
- --
- William E. Rote
- Senior Vice President, Research and Development
- 2.05M
- Elizabeth E. Reed
- Senior Vice President, General Counsel and Corporate Secretary
- 2.02M
- Gary A. Lyons
- Chairman of the Board
- 392.98K
- Ruth WilliaBrinkley
- Independent Director
- 365.48K
- John A. Orwin, M.B.A.
- Independent Director
- 372.98K
- Ron Squarer
- Independent Director
- 367.98K
- Timothy P. Coughlin
- Independent Director
- 385.48K
- Sandra E. Poole
- Independent Director
- 369.86K
- Jeffrey A. Meckler
- Independent Director
- 379.98K
- Dr. Suzanne L. Bruhn, PhD
- Independent Director
- 372.36K
- Dr. Roy D. Baynes, M.D.,PhD
- Independent Director
- 376.73K